Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Su

Showing results (1011-1020 of 1,172) with videos related to

Pageof 118
Sort By:
Plos One|April 16, 2015
HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinomaChi-Chung Wang, Kang-Yi Su, Hsuan-Yu Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patientsKuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, et al.
Acta Pharmacologica Sinica|January 24, 2017
Marine-derived chromopeptide A, a novel class I HDAC inhibitor, suppresses human prostate cancer cell proliferation and migrationJing-Ya Sun, Ji-Dong Wang, Xin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancerKang-Yi Su, Hsuan-Yu Chen, Ker-Chau Li, et al.
Translational Psychiatry|February 9, 2022
ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association studyZhe Lu, Yuyanan Zhang, Hao Yan, et al.
Cancer Research and Treatment|January 16, 2018
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung AdenocarcinomaYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
International Journal of Ophthalmology|February 19, 2025
Making stereopsis related to the ability of ocular deviation: a new paradigm for assessment of intermittent exotropiaJian-Bing Li, Wan-Ting Kong, Tao Shen, et al.
Nucleic Acids Research|October 13, 2007
PBmice: an integrated database system of piggyBac (PB) insertional mutations and their characterizations in miceLing V Sun, Ke Jin, Yiming Liu, et al.
Stem Cell Reports|June 17, 2022
CD49b identifies functionally and epigenetically distinct subsets of lineage-biased hematopoietic stem cellsEce Somuncular, Julia Hauenstein, Prajakta Khalkar, et al.
Neurobiology of Aging|April 15, 2018
Aerobic glycolysis and tau deposition in preclinical Alzheimer's diseaseAndrei G Vlassenko, Brian A Gordon, Manu S Goyal, et al.
Pageof 118

Showing results (1011-1020 of 1,172) with videos related to

Sort By:
Pageof 118
Plos One|April 16, 2015
HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinomaChi-Chung Wang, Kang-Yi Su, Hsuan-Yu Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patientsKuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, et al.
Acta Pharmacologica Sinica|January 24, 2017
Marine-derived chromopeptide A, a novel class I HDAC inhibitor, suppresses human prostate cancer cell proliferation and migrationJing-Ya Sun, Ji-Dong Wang, Xin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancerKang-Yi Su, Hsuan-Yu Chen, Ker-Chau Li, et al.
Translational Psychiatry|February 9, 2022
ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association studyZhe Lu, Yuyanan Zhang, Hao Yan, et al.
Cancer Research and Treatment|January 16, 2018
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung AdenocarcinomaYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
International Journal of Ophthalmology|February 19, 2025
Making stereopsis related to the ability of ocular deviation: a new paradigm for assessment of intermittent exotropiaJian-Bing Li, Wan-Ting Kong, Tao Shen, et al.
Nucleic Acids Research|October 13, 2007
PBmice: an integrated database system of piggyBac (PB) insertional mutations and their characterizations in miceLing V Sun, Ke Jin, Yiming Liu, et al.
Stem Cell Reports|June 17, 2022
CD49b identifies functionally and epigenetically distinct subsets of lineage-biased hematopoietic stem cellsEce Somuncular, Julia Hauenstein, Prajakta Khalkar, et al.
Neurobiology of Aging|April 15, 2018
Aerobic glycolysis and tau deposition in preclinical Alzheimer's diseaseAndrei G Vlassenko, Brian A Gordon, Manu S Goyal, et al.
Pageof 118